Latest / The Diagnostics & Lab Testing Business Brief
Roche cobas smart e CE Mark, Abbott Launches Next-Gen Oncodetect MRD, Nautilus Joins ARPA-H SEEDS — Oct 27, 2026
The Diagnostics & Lab Testing Business Brief — Tuesday, October 27, 2026
The business behind the tests. Today's developments shaping the diagnostics industry.
Roche receives CE Mark for cobas smart e immunoanalyser: announced Oct 27, 2026 — a compact, standalone benchtop platform (under 1 m², ~0.9 m², 36 reagent positions) with a planned menu of over 100 high-medical-value assays, reaction times of 18 minutes or less for more than 90% of immunoassays, the same universal reagents and Elecsys® technology as Roche's high-throughput platforms, and one minute of daily operator intervention. CE…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.